Baidu
map

J Thromb Haemost:卒中发生急性出血并发症与低涂层血小板水平相关

2015-10-29 phylis 译 MedSci原创

背景:涂层血小板是胶原蛋白和凝血酶刺激下促凝血的血小板。涂层血小板水平在非腔隙性缺血性卒中的患者中升高,在自发性脑出血的患者中降低。 目的:为了调查非腔隙性缺血性卒中患者住院期间发生急性出血是否与低涂层血小板相关。方法:检测385名非腔隙性卒中患者的涂层血小板水平。应用颅内出血或明显的颅外出血(血红蛋白下降超过2 g/dL)。 应用Cochrane-Armitage趋势检验比较不同涂层血小板的患者

背景:涂层血小板是胶原蛋白和凝血酶刺激下促凝血的血小板。涂层血小板水平在非腔隙性缺血性卒中的患者中升高,在自发性脑出血的患者中降低。

目的:为了调查非腔隙性缺血性卒中患者住院期间发生急性出血是否与低涂层血小板相关。

方法:检测385名非腔隙性卒中患者的涂层血小板水平。应用颅内出血或明显的颅外出血(血红蛋白下降超过2 g/dL)。 应用Cochrane-Armitage趋势检验比较不同涂层血小板的患者的急性出血并发症的发生。应用Logistic回归评估涂层血小板和出血并发症的相关性。

结果:15名(3.9%)患者发生了出血并发症。其中,4名为颅内出血,11名存在颅外出血。不同血小板水平,出血并发症的发生率不同:涂层血小板在前三分之一(涂层血小板< 35.5%)的患者为10.2%,涂层血小板中间三分之一为1.5%,涂层血小板在后三分之一(涂层血小板≥ 47.5%)的为0。Logistic回归分析表明涂层血小板是涂层血小板高于患者发生出血并发症的概率的14.59倍(95% CI: 3.24-65.7)。

结论:促凝血小板水平较低与非腔隙性缺血性卒中发生急性出血并发症相关。这些结果表明在卒中早期阶段,涂层血小板在对患者进行风险/获益评估中的重要作用。

原文出处:

Prodan CI, Stoner JA, Dale GL. Acute hemorrhagic complications are associated with lower coated-platelet levels in non-lacunar brain infarction. J Thromb Haemost. 2015,Oct 1.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1756831, encodeId=7f591e5683174, content=<a href='/topic/show?id=b6b252205af' target=_blank style='color:#2F92EE;'>#急性出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52205, encryptionId=b6b252205af, topicName=急性出血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6e37239771, createdName=1194695146_61857359, createdTime=Wed Jan 13 11:07:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008211, encodeId=3d18200821109, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Thu Dec 03 15:07:00 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076788, encodeId=b16320e6788d4, content=<a href='/topic/show?id=b7cc65e2596' target=_blank style='color:#2F92EE;'>#涂层血小板#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65725, encryptionId=b7cc65e2596, topicName=涂层血小板)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Mon Nov 30 03:07:00 CST 2015, time=2015-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757677, encodeId=07cd1e5767794, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 04 01:07:00 CST 2016, time=2016-10-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1756831, encodeId=7f591e5683174, content=<a href='/topic/show?id=b6b252205af' target=_blank style='color:#2F92EE;'>#急性出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52205, encryptionId=b6b252205af, topicName=急性出血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6e37239771, createdName=1194695146_61857359, createdTime=Wed Jan 13 11:07:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008211, encodeId=3d18200821109, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Thu Dec 03 15:07:00 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076788, encodeId=b16320e6788d4, content=<a href='/topic/show?id=b7cc65e2596' target=_blank style='color:#2F92EE;'>#涂层血小板#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65725, encryptionId=b7cc65e2596, topicName=涂层血小板)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Mon Nov 30 03:07:00 CST 2015, time=2015-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757677, encodeId=07cd1e5767794, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 04 01:07:00 CST 2016, time=2016-10-04, status=1, ipAttribution=)]
    2015-12-03 changfy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1756831, encodeId=7f591e5683174, content=<a href='/topic/show?id=b6b252205af' target=_blank style='color:#2F92EE;'>#急性出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52205, encryptionId=b6b252205af, topicName=急性出血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6e37239771, createdName=1194695146_61857359, createdTime=Wed Jan 13 11:07:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008211, encodeId=3d18200821109, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Thu Dec 03 15:07:00 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076788, encodeId=b16320e6788d4, content=<a href='/topic/show?id=b7cc65e2596' target=_blank style='color:#2F92EE;'>#涂层血小板#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65725, encryptionId=b7cc65e2596, topicName=涂层血小板)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Mon Nov 30 03:07:00 CST 2015, time=2015-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757677, encodeId=07cd1e5767794, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 04 01:07:00 CST 2016, time=2016-10-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1756831, encodeId=7f591e5683174, content=<a href='/topic/show?id=b6b252205af' target=_blank style='color:#2F92EE;'>#急性出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52205, encryptionId=b6b252205af, topicName=急性出血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6e37239771, createdName=1194695146_61857359, createdTime=Wed Jan 13 11:07:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008211, encodeId=3d18200821109, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Thu Dec 03 15:07:00 CST 2015, time=2015-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076788, encodeId=b16320e6788d4, content=<a href='/topic/show?id=b7cc65e2596' target=_blank style='color:#2F92EE;'>#涂层血小板#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65725, encryptionId=b7cc65e2596, topicName=涂层血小板)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Mon Nov 30 03:07:00 CST 2015, time=2015-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757677, encodeId=07cd1e5767794, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 04 01:07:00 CST 2016, time=2016-10-04, status=1, ipAttribution=)]
    2016-10-04 丁鹏鹏

相关资讯

Front Aging Neurosci:老年缺血性卒中患者,女性预后更差

背景:尽管在男性卒中的发生率和死亡率较高,但卒中对女性有着更大的临床影响。然而,在老年卒中患者中的性别差异尚不清楚。因此,研究人员旨在评估老年卒中患者的性别差异。方法:研究人员招募了中国天津神经专科医院2005年到2013年期间1484名急性缺血性卒中(AIS)患者(大于75岁)。记录患者的卒中类型,严重程度,危险因素,以及卒中后3个月和12个月预后。结果:与男性患者相比,女性患者发生严重卒中(1

Neurology:对存在未破裂颅内动脉瘤的缺血性卒中进行全身溶栓是安全的

目的:研究人员进行中心研究和综合meta分析,旨在确定存在未破裂颅内动脉瘤(UIA)的急性缺血性卒中(AIS)患者静脉溶栓(IVT)的安全性。方法:研究人员分析了4年间4个卒中中心进行IVT治疗的AIS患者的数据。入院期间,所有患者常规行CT或MRI检查。基于神经影像学报告确定存在UIA。症状性脑内出血(sICH)由ICH的影像学证据和NIHSS分数增加超过4分确定。根据PRISMA指南对存在未破

Acta Neurol Scand:缺血性卒中患者的健康预后及花费

目的:随着发展,卒中的死亡率下降。然而,对患者的健康相关生活质量(HRQoL),质量校正生存时间(QALYs)以及花费了解较少。研究人员应用芬兰地区十年前收集的两个数据集来分析这些情况。方法:两个研究(Study1:1989-1991,Study2:2001-2003)中共有468和355名首发缺血性卒中的患者,对其随访一年。比较病例致死率,15D测量的 HRQoL, QALYs,花费及第一年花费

Environ Res:空气污染与缺血性卒中相关存在种族差异

目的:为了调查空气污染(PM2.5和臭氧)短期改变与有住在一个具有两个种族的地方的人群发生缺血性卒中的风险相关性,评估是否这种相关有种族差异。方法:研究者2000年到2012期间的BASIC计划中识别缺血性卒中的患者。测量同一天或者滞后1-3天的PM2.5(24h)和臭氧(8h最大值)的水平,并且应用条件Logistic回归中时间分层交叉设计模型评估环境污染和急性缺血性卒中发生的相关性。研究者探究

Stroke:中年人轻度饮酒与卒中和脑出血的发生无关,但中重度有害

背景和目的:在美国饮酒是非常常见的,并且少量或中等量的酒精对心血管系统是有利的。酒精与卒中发生的关系仍然存在争议。在两种人的队列研究中,研究人员调查了自称饮酒的中年人和缺血性卒中和脑出血(ICH)发生的关系。方法:在社区动脉粥样硬化风险研究中,12433名从未饮酒或当前正在饮酒者,年龄45到64岁。受试者自称每周常饮啤酒,白酒或烈酒。研究人员校正性别,种族后,用多变量Cox风险比例回归评估与从未饮

Stroke:和肽素可预测缺血性卒中患者血管事件的再发

背景和目的:和肽素作为精氨酸加压素原羧基末端的一部分,是心肌梗死和心衰患者预后的有用的标记物。高水平的和肽素与缺血性卒中和短暂性脑缺血发作(TIA)不良功能预后和死亡率升高相关。然而,和肽素是否能预测TIA和卒中后发生血管事件的风险尚不清楚。方法:招募了从2002年到2007年牛津血管研究中TIA或缺血性卒中患者,检测和肽素水平,并随访到2014年。应用Cox回归分析相关的再发血管事件的风险。结果

Baidu
map
Baidu
map
Baidu
map